Sarepta Therapeutics (SRPT) Revenue Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 16.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.45% |
| Dec 31, 2025 | 37.82% |
| Sep 30, 2025 | 24.33% |
| Jun 30, 2025 | 42.50% |
| Mar 31, 2025 | 82.31% |
| Dec 31, 2024 | 80.49% |
| Sep 30, 2024 | 35.11% |
| Jun 30, 2024 | 36.78% |
| Mar 31, 2024 | 41.18% |
| Dec 31, 2023 | 174.16% |
| Sep 30, 2023 | 145.25% |
| Jun 30, 2023 | -5.08% |
| Mar 31, 2023 | 167.62% |
| Dec 31, 2022 | 19.11% |
| Sep 30, 2022 | 28.01% |
| Jun 30, 2022 | 30.67% |
| Mar 31, 2022 | -36.76% |
| Dec 31, 2021 | 9.88% |
| Sep 30, 2021 | 34.13% |
| Jun 30, 2021 | 24.48% |
| Mar 31, 2021 | 31.51% |
| Dec 31, 2020 | -26.77% |
| Sep 30, 2020 | -21.19% |
| Jun 30, 2020 | -9.42% |
| Mar 31, 2020 | -6.81% |
| Dec 31, 2017 | 1,184.91% |
| Sep 30, 2017 | 251.41% |
| Jun 30, 2017 | 138.43% |
| Mar 31, 2017 | 38.98% |